Evidence map›Paper›PMID 34574060›Full record

ReviewDiagnostics (Basel, Switzerland)2021

A New Dawn for the Use of Artificial Intelligence in Gastroenterology, Hepatology and Pancreatology.

Akihiko Oka, Norihisa Ishimura, Shunji Ishihara

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Akihiko OkaDepartment of Internal Medicine II, Faculty of Medicine, Shimane University, Izumo 693-8501, Shimane, Japan.ORCID 0000-0001-6451-8413
Norihisa IshimuraDepartment of Internal Medicine II, Faculty of Medicine, Shimane University, Izumo 693-8501, Shimane, Japan.ORCID 0000-0001-8039-3155
Shunji IshiharaDepartment of Internal Medicine II, Faculty of Medicine, Shimane University, Izumo 693-8501, Shimane, Japan.

Funding

Japan Society for the Promotion of Science 21K15951
6 · The paper itself

Abstract

Artificial intelligence (AI) is rapidly becoming an essential tool in the medical field as well as in daily life. Recent developments in deep learning, a subfield of AI, have brought remarkable advances in image recognition, which facilitates improvement in the early detection of cancer by endoscopy, ultrasonography, and computed tomography. In addition, AI-assisted big data analysis represents a great step forward for precision medicine. This review provides an overview of AI technology, particularly for gastroenterology, hepatology, and pancreatology, to help clinicians utilize AI in the near future.

Indexed as

deep learningendoscopymachine learningradiologyultrasonography

Identifiers

PMID34574060
PMCPMC8468082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.